1. Home
  2. CCIF vs HRTX Comparison

CCIF vs HRTX Comparison

Compare CCIF & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCIF

Carlyle Credit Income Fund Shares of Beneficial Interest

N/A

Current Price

$1.43

Market Cap

48.7M

Sector

Finance

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.27

Market Cap

54.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCIF
HRTX
Founded
2011
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.7M
54.1M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
CCIF
HRTX
Price
$1.43
$0.27
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
143.8K
★ 4.8M
Earning Date
01-01-0001
11-09-2026
Dividend Yield
★ 25.90%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $154,904,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.36
52 Week Low
$1.50
$0.26
52 Week High
$5.33
$1.58

Technical Indicators

Market Signals
Indicator
CCIF
HRTX
Relative Strength Index (RSI) 25.13 40.19
Support Level N/A N/A
Resistance Level $2.91 $0.44
Average True Range (ATR) 0.13 0.04
MACD -0.01 -0.00
Stochastic Oscillator 23.28 9.91

Price Performance

Historical Comparison
CCIF
HRTX

About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: